Orbital Syndromes

 

 Buy Article Permissions and Reprints

ABSTRACT

The orbit is a complex anatomical structure with unique properties not observed in other regions of the body. Composed of seven bones, the orbit is filled by the eye, optic nerve, lacrimal gland, extraocular muscles, peripheral motor and sensory nerves, fat, arteries, and veins. All these structures are intimately related to one another within an intricate framework of connective tissue. A variety of traumatic, vascular, inflammatory, infectious, and neoplastic processes can affect the orbit and its structures. Aside from the many primary orbital diseases, systemic disorders and pathological processes from neighboring structures (eye, ocular adnexa, oral cavity, paranasal sinuses, and intracranial cavity) can involve the orbit. A careful history and complete physical examination, with special attention to the orbit and ocular adnexa, are required to identify subtle orbital abnormalities that otherwise could be overlooked or mistakenly contributed to a nonorbital process. This article reviews the pertinent orbital anatomy, discusses the clinical evaluation and manifestations of orbital syndromes, and highlights several important orbital syndromes germane to the neurologist, including thyroid-associated orbitopathy, nonspecific orbital inflammation (also known as inflammatory orbital pseudotumor), perineural orbital invasion of cutaneous squamous cell carcinoma, rhino-orbital-cerebral mucormycosis, and carotid-cavernous sinus fistula.

REFERENCES

• 1 Wilson M W, Grossniklaus H E. Orbital disease in North America.  Ophthalmol Clin North Am. 1996;  9 539-547
  PubMedGoogle Scholar
• 2 Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. Philadelphia; Lippincott Williams & Wilkins 2003
  Google Scholar
• 3 Doxanas M T, Anderson R L. Clinical Orbital Anatomy. Baltimore; Williams & Wilkins 1984
  Google Scholar
• 4 Rhoton A L, Natori Y. The Orbit and Sellar Region: Microsurgical Anatomy and Operative Approaches. New York; Thieme Medical Publishers 1996
  Google Scholar
• 5 Rootman J, Stewart B, Goldberg R A. Orbital Surgery: A Conceptual Approach. Philadelphia; Lippincott-Raven Publishers 1995
  Google Scholar
• 6 Hayek G, Mercier P, Fournier H D. Anatomy of the orbit and its surgical approach.  Adv Tech Stand Neurosurg. 2006;  31 35-71
  Google Scholar
• 7 Cheung N, McNab A A. Venous anatomy of the orbit.  Invest Ophthalmol Vis Sci. 2003;  44 988-995
  CrossrefPubMedGoogle Scholar
• 8 Otto C S, Coppit G L, Mazzoli R A et al.. Gaze-evoked amaurosis: a report of five cases.  Ophthalmology. 2003;  110 322-326
  CrossrefPubMedGoogle Scholar
• 9 Cline R A, Rootman J. Enophthalmos: a clinical review.  Ophthalmology. 1984;  91 229-237
  CrossrefPubMedGoogle Scholar
• 10 Chang B Y, Cunniffe G, Hutchinson C. Enophthalmos associated with primary breast carcinoma.  Orbit. 2002;  21 307-310
  CrossrefPubMedGoogle Scholar
• 11 Kupersmith M J. Neuro-Vascular Neuro-Ophthalmology. Berlin; Springer-Verlag 1993
  Google Scholar
• 12 Coday M P, Netland P A, Dallow R L. Thyroid-associated ophthalmolopathy (Graves' disease). In: Albert DM, Jakobiec FA Principles and Practice of Ophthalmology. Vol. 5. Philadelphia; WB Saunders Company 2000: 4742-4759
  Google Scholar
• 13 Chang E L, Rubin P A. Upper and lower eyelid retraction.  Int Ophthalmol Clin. 2002;  42 45-59
  PubMedGoogle Scholar
• 14 Gaymard B, Huynh C, Laffont I. Unilateral eyelid retraction.  J Neurol Neurosurg Psychiatry. 2000;  68 390-392
  CrossrefPubMedGoogle Scholar
• 15 Yeh S, Foroozan R. Orbital apex syndrome.  Curr Opin Ophthalmol. 2004;  15 490-498
  CrossrefPubMedGoogle Scholar
• 16 Ettl A, Salomonowitz E, Koornneef L, Zonneveld F W. High-resolution MR imaging anatomy of the orbit: correlation with comparative cryosectional anatomy.  Radiol Clin North Am. 1998;  36 1021-1045 , ix
  CrossrefPubMedGoogle Scholar
• 17 Aviv R I, Miszkiel K. Orbital imaging: part 2. Intraorbital pathology.  Clin Radiol. 2005;  60 288-307
  CrossrefPubMedGoogle Scholar
• 18 Herrick R C, Hayman L A, Taber K H, Diaz-Marchan P J, Kuo M D. Artifacts and pitfalls in MR imaging of the orbit: a clinical review.  Radiographics. 1997;  17 707-724
  PubMedGoogle Scholar
• 19 Belden C J, Zinreich S J. Orbital imaging techniques.  Semin Ultrasound CT MR. 1997;  18 413-422
  CrossrefPubMedGoogle Scholar
• 20 Simon J, Szumowski J, Totterman S et al.. Fat-suppression MR imaging of the orbit.  AJNR Am J Neuroradiol. 1988;  9 961-968
  PubMedGoogle Scholar
• 21 Barakos J A, Dillon W P, Chew W M. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging.  Radiology. 1991;  179 191-198
  PubMedGoogle Scholar
• 22 Lieb W E. Color Doppler imaging of the eye and orbit.  Radiol Clin North Am. 1998;  36 1059-1071
  CrossrefPubMedGoogle Scholar
• 23 Chen C C, Chang P C, Shy C G, Chen W S, Hung H C. CT angiography and MR angiography in the evaluation of carotid cavernous sinus fistula prior to embolization: a comparison of techniques.  AJNR Am J Neuroradiol. 2005;  26 2349-2356
  PubMedGoogle Scholar
• 24 Bahn R S, Heufelder A E. Pathogenesis of Graves' ophthalmopathy.  N Engl J Med. 1993;  329 1468-1475
  CrossrefPubMedGoogle Scholar
• 25 Gorman C A. Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis.  Mayo Clin Proc. 1983;  58 515-519
  PubMedGoogle Scholar
• 26 Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives.  Endocr Rev. 2000;  21 168-199
  CrossrefPubMedGoogle Scholar
• 27 Kazim M, Goldberg R A, Smith T J. Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy.  Arch Ophthalmol. 2002;  120 380-386
  PubMedGoogle Scholar
• 28 Garrity J A, Bahn R S. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.  Am J Ophthalmol. 2006;  142 147-153
  CrossrefPubMedGoogle Scholar
• 29 Volpe N J, Sbarbaro J A, Gendron Livingston K, Galetta S L, Liu G T, Balcer L J. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.  Am J Ophthalmol. 2006;  142 75-81
  CrossrefPubMedGoogle Scholar
• 30 Bartley G B, Fatourechi V, Kadrmas E F et al.. Clinical features of Graves' ophthalmopathy in an incidence cohort.  Am J Ophthalmol. 1996;  121 284-290
  CrossrefPubMedGoogle Scholar
• 31 Peyster R G, Ginsberg F, Silber J H, Adler L P. Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis.  AJR Am J Roentgenol. 1986;  146 459-464
  PubMedGoogle Scholar
• 32 Dallow R L, Netland P A. Management of thyroid-associated orbitopathy (Graves' disease). In: Albert DM, Jakobiec FA Principles and Practice of Ophthalmology. Vol. 4. Philadelphia; WB Saunders Company 2000: 3082-3099
  Google Scholar
• 33 Mombaerts I, Goldschmeding R, Schlingemann R O, Koornneef L. What is orbital pseudotumor?.  Surv Ophthalmol. 1996;  41 66-78
  CrossrefPubMedGoogle Scholar
• 34 Snebold N G. Noninfectious orbital inflammations and vasculitis. In: Albert DM, Jakobiec FA Principles and Practice of Ophthalmology. Vol. 4. Philadelphia; WB Saunders Company 2000: 3100-3121
  Google Scholar
• 35 Weber A L, Romo L V, Sabates N R. Pseudotumor of the orbit: clinical, pathologic, and radiologic evaluation.  Radiol Clin North Am. 1999;  37 151-168
  CrossrefPubMedGoogle Scholar
• 36 Mahr M A, Salomao D R, Garrity J A. Inflammatory orbital pseudotumor with extension beyond the orbit.  Am J Ophthalmol. 2004;  138 396-400
  CrossrefPubMedGoogle Scholar
• 37 Mombaerts I, Schlingemann R O, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors?.  Ophthalmology. 1996;  103 521-528
  PubMedGoogle Scholar
• 38 Kline L B, Hoyt W F. The Tolosa-Hunt syndrome.  J Neurol Neurosurg Psychiatry. 2001;  71 577-582
  CrossrefPubMedGoogle Scholar
• 39 Yuen S J, Rubin P A. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome.  Arch Ophthalmol. 2003;  121 491-499
  CrossrefPubMedGoogle Scholar
• 40 Rootman J, Nugent R. The classification and management of acute orbital pseudotumors.  Ophthalmology. 1982;  89 1040-1048
  PubMedGoogle Scholar
• 41 Weissler M C, Miller E, Fortune M A. Sclerosing orbital pseudotumor: a unique clinicopathologic entity.  Ann Otol Rhinol Laryngol. 1989;  98 496-501
  PubMedGoogle Scholar
• 42 Bernardino C R, Davidson R S, Maus M, Spaeth G L. Angle-closure glaucoma in association with orbital pseudotumor.  Ophthalmology. 2001;  108 1603-1606
  CrossrefPubMedGoogle Scholar
• 43 Purvin V, Kawasaki A, Jacobson D M. Optic perineuritis: clinical and radiographic features.  Arch Ophthalmol. 2001;  119 1299-1306
  CrossrefPubMedGoogle Scholar
• 44 McKinnon S G, Gentry L R. Systemic diseases involving the orbit.  Semin Ultrasound CT MR. 1998;  19 292-308
  CrossrefPubMedGoogle Scholar
• 45 Weber A L, Jakobiec F A, Sabates N R. Lymphoproliferative disease of the orbit.  Neuroimaging Clin N Am. 1996;  6 93-111
  PubMedGoogle Scholar
• 46 Gordon L K. Diagnostic dilemmas in orbital inflammatory disease.  Ocul Immunol Inflamm. 2003;  11 3-15
  PubMedGoogle Scholar
• 47 Jabs D A, Rosenbaum J T, Foster C S et al.. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.  Am J Ophthalmol. 2000;  130 492-513
  CrossrefPubMedGoogle Scholar
• 48 Smith J R, Rosenbaum J T. A role for methotrexate in the management of non-infectious orbital inflammatory disease.  Br J Ophthalmol. 2001;  85 1220-1224
  PubMedGoogle Scholar
• 49 Garrity J A, Coleman A W, Matteson E L, Eggenberger E R, Waitzman D M. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.  Am J Ophthalmol. 2004;  138 925-930
  CrossrefPubMedGoogle Scholar
• 50 Johnson T M, Rowe D E, Nelson B R, Swanson N A. Squamous cell carcinoma of the skin (excluding lip and oral mucosa).  J Am Acad Dermatol. 1992;  26 467-484
  CrossrefPubMedGoogle Scholar
• 51 Mohs F E, Lathrop T G. Modes of spread of cancer of skin.  AMA Arch Derm Syphilol. 1952;  66 427-439
  CrossrefPubMedGoogle Scholar
• 52 Cruveilhier J. Maladies des Nerfs: Anatomie Pahologique du Corps Humain. Vol. 2. Paris; Bailliere 1842: 1835-1842
  Google Scholar
• 53 Dodd G D, Dolan P A, Ballantyne A J, Ibanez M L, Chau P. The dissemination of tumors of the head and neck via the cranial nerves.  Radiol Clin North Am. 1970;  8 445-461
  PubMedGoogle Scholar
• 54 Veness M J, Biankin S. Perineural spread leading to orbital invasion from skin cancer.  Australas Radiol. 2000;  44 296-302
  CrossrefPubMedGoogle Scholar
• 55 Smith J B, Bishop V L, Francis I C, Kos S, Kneale K A. Ophthalmic manifestations of perineural spread of facial skin malignancy.  Aust NZ J Ophthalmol. 1990;  18 197-205
  PubMedGoogle Scholar
• 56 Clouston P D, Sharpe D M, Corbett A J, Kos S, Kennedy P J. Perineural spread of cutaneous head and neck cancer: its orbital and central neurologic complications.  Arch Neurol. 1990;  47 73-77
  CrossrefPubMedGoogle Scholar
• 57 Caldemeyer K S, Mathews V P, Righi P D, Smith R R. Imaging features and clinical significance of perineural spread or extension of head and neck tumors.  Radiographics. 1998;  18 97-110
  CrossrefPubMedGoogle Scholar
• 58 Rowe D E, Carroll R J, Day Jr C L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection.  J Am Acad Dermatol. 1992;  26 976-990
  CrossrefPubMedGoogle Scholar
• 59 Alam M, Ratner D. Cutaneous squamous-cell carcinoma.  N Engl J Med. 2001;  344 975-983
  CrossrefPubMedGoogle Scholar
• 60 Barksdale S K, O'Connor N, Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma: determinants of risk of recurrence, metastasis, and development of subsequent skin cancers.  Surg Oncol Clin N Am. 1997;  6 625-638
  PubMedGoogle Scholar
• 61 McNab A A, Francis I C, Benger R, Crompton J L. Perineural spread of cutaneous squamous cell carcinoma via the orbit: clinical features and outcome in 21 cases.  Ophthalmology. 1997;  104 1457-1462
  PubMedGoogle Scholar
• 62 Bowyer J D, Sullivan T J, Whitehead K J, Kelly L E, Allison R W. The management of perineural spread of squamous cell carcinoma to the ocular adnexae.  Ophthal Plast Reconstr Surg. 2003;  19 275-281
  CrossrefPubMedGoogle Scholar
• 63 Lawrence N, Cottel W I. Squamous cell carcinoma of skin with perineural invasion.  J Am Acad Dermatol. 1994;  31 30-33
  CrossrefPubMedGoogle Scholar
• 64 Carter R L, Foster C S, Dinsdale E A et al.. Perineural spread by squamous cell carcinomas of the head and neck: a morphological study using antiaxonal and antimyelin monoclonal antibodies.  J Clin Pathol. 1983;  36 269-275
  CrossrefPubMedGoogle Scholar
• 65 Ginsberg L E. Imaging of perineural tumor spread in head and neck cancer.  Semin Ultrasound CT MR. 1999;  20 175-186
  CrossrefPubMedGoogle Scholar
• 66 Moore C E, Hoyt W F, North J B. Painful ophthalmoplegia following treated squamous carcinoma of the forehead: orbital apex involvement from centripetal spread via the supraorbital nerve.  Med J Aust. 1976;  1 657-659
  PubMedGoogle Scholar
• 67 Esmaeli B, Ginsberg L, Goepfert H, Deavers M. Squamous cell carcinoma with perineural invasion presenting as a Tolosa-Hunt-like syndrome: a potential pitfall in diagnosis.  Ophthal Plast Reconstr Surg. 2000;  16 450-452
  CrossrefPubMedGoogle Scholar
• 68 Trobe J D, Hood C I, Parsons J T, Quisling R G. Intracranial spread of squamous carcinoma along the trigeminal nerve.  Arch Ophthalmol. 1982;  100 608-611
  CrossrefPubMedGoogle Scholar
• 69 Williams L S, Mancuso A A, Mendenhall W M. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis.  Int J Radiat Oncol Biol Phys. 2001;  49 1061-1069
  CrossrefPubMedGoogle Scholar
• 70 Williams L S. Advanced concepts in the imaging of perineural spread of tumor to the trigeminal nerve.  Top Magn Reson Imaging. 1999;  10 376-383
  PubMedGoogle Scholar
• 71 Esmaeli B, Ahmadi M A, Gillenwater A M, Faustina M M, Amato M. The role of supraorbital nerve biopsy in cutaneous malignancies of the periocular region.  Ophthal Plast Reconstr Surg. 2003;  19 282-286
  CrossrefPubMedGoogle Scholar
• 72 Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management.  Clin Microbiol Rev. 2005;  18 556-569
  CrossrefPubMedGoogle Scholar
• 73 Ribes J A, Vanover-Sams C L, Baker D J. Zygomycetes in human disease.  Clin Microbiol Rev. 2000;  13 236-301
  CrossrefPubMedGoogle Scholar
• 74 Yohai R A, Bullock J D, Aziz A A, Markert R J. Survival factors in rhino-orbital-cerebral mucormycosis.  Surv Ophthalmol. 1994;  39 3-22
  CrossrefPubMedGoogle Scholar
• 75 Harril W C, Stewart M G, Lee A G, Cernoch P. Chronic rhinocerebral mucormycosis.  Laryngoscope. 1996;  106 1292-1297
  CrossrefPubMedGoogle Scholar
• 76 Dhiwakar M, Thakar A, Bahadur S. Improving outcomes in rhinocerebral mucormycosis: early diagnostic pointers and prognostic factors.  J Laryngol Otol. 2003;  117 861-865
  PubMedGoogle Scholar
• 77 Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L. Mucormycosis: early diagnosis and treatment.  Rev Laryngol Otol Rhinol (Bord). 2004;  125 127-131
  PubMedGoogle Scholar
• 78 Ferry A P, Abedi S. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis): a report of 16 personally observed cases.  Ophthalmology. 1983;  90 1096-1104
  PubMedGoogle Scholar
• 79 Safar A, Marsan J, Marglani O, Al-Sebeih K, Al-Harbi J, Valvoda M. Early identification of rhinocerebral mucormycosis.  J Otolaryngol. 2005;  34 166-171
  PubMedGoogle Scholar
• 80 Bhansali A, Bhadada S, Sharma A et al.. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes.  Postgrad Med J. 2004;  80 670-674
  CrossrefPubMedGoogle Scholar
• 81 Nussbaum E S, Hall W A. Rhinocerebral mucormycosis: changing patterns of disease.  Surg Neurol. 1994;  41 152-156
  CrossrefPubMedGoogle Scholar
• 82 Bodenstein N P, McIntosh W A, Vlantis A C, Urquhart A C. Clinical signs of orbital ischemia in rhino-orbitocerebral mucormycosis.  Laryngoscope. 1993;  103 1357-1361
  PubMedGoogle Scholar
• 83 Peterson K L, Wang M, Canalis R F, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options.  Laryngoscope. 1997;  107 855-862
  CrossrefPubMedGoogle Scholar
• 84 Hargrove R N, Wesley R E, Klippenstein K A, Fleming J C, Haik B G. Indications for orbital exenteration in mucormycosis.  Ophthal Plast Reconstr Surg. 2006;  22 286-291
  CrossrefPubMedGoogle Scholar
• 85 Barrow D L, Spector R H, Braun I F, Landman J A, Tindall S C, Tindall G T. Classification and treatment of spontaneous carotid-cavernous sinus fistulas.  J Neurosurg. 1985;  62 248-256
  PubMedGoogle Scholar
• 86 Miller N R. Carotid-cavernous sinus fistulas. In: Miller NR, Newman NJ, Biousse V, Kerrison JB Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol. 2. Baltimore; Williams & Wilkins 2005: 2263-2296
  Google Scholar
• 87 Bhatti M T, Peters K R. A red eye and then a really red eye.  Surv Ophthalmol. 2003;  48 224-229
  CrossrefPubMedGoogle Scholar
• 88 Keltner J L, Satterfield D, Dublin A B, Lee B C. Dural and carotid cavernous sinus fistulas: diagnosis, management, and complications.  Ophthalmology. 1987;  94 1585-1600
  CrossrefPubMedGoogle Scholar
• 89 Sergott R C, Grossman R I, Savino P J, Bosley T M, Schatz N J. The syndrome of paradoxical worsening of dural-cavernous sinus arteriovenous malformations.  Ophthalmology. 1987;  94 205-212
  PubMedGoogle Scholar
• 90 Barnwell S L, O'Neill O R. Endovascular therapy of carotid cavernous fistulas.  Neurosurg Clin N Am. 1994;  5 485-495
  PubMedGoogle Scholar

M. Tariq BhattiM.D. 

Departments of Ophthalmology and Medicine, Division of Neurology, Duke University Eye Center

2351 Erwin Road, DUMC 3802, Durham, NC 27710-3802

Email: tariq.bhatti@duke.edu